Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Severe Congenital Adrenal Hyperplasia Presenting as Bilateral Testicular Tumors and Azoospermia in the Third Decade of Life.

Sarfati J, Vatier C, Keller I, Guéchot J, Bellanné-Chantelot C, Christin-Maitre S.

J Endocr Soc. 2018 Jul 4;2(9):997-1000. doi: 10.1210/js.2018-00103. eCollection 2018 Sep 1.

2.

Heterogeneous Prognoses for pT3 Papillary Thyroid Carcinomas and Impact of Delayed Risk Stratification.

Tavarelli M, Sarfati J, Chereau N, Tissier F, Golmard JL, Ghander C, Lussey-Lepoutre C, Trésallet C, Menegaux F, Leenhardt L, Buffet C.

Thyroid. 2017 Jun;27(6):778-786. doi: 10.1089/thy.2016.0512. Epub 2017 Apr 24.

PMID:
28351220
3.

Pituitary Adenoma Recurrence Suspected on Central Hyperthyroidism Despite Empty Sella and Confirmed by 68Ga-DOTA-TOC PET/CT.

Gauthé M, Sarfati J, Bourcigaux N, Christin-Maitre S, Talbot JN, Montravers F.

Clin Nucl Med. 2017 Jun;42(6):454-455. doi: 10.1097/RLU.0000000000001628.

PMID:
28263215
4.

Hypertrophic Osteoarthropathy and Follicular Thyroid Cancer: A Rare Paraneoplastic Syndrome.

Tavarelli M, Sarfati J, De Gennes C, Haroche J, Buffet C, Ghander C, Simon JM, Ménégaux F, Leenhardt L.

Eur Thyroid J. 2015 Dec;4(4):266-70. doi: 10.1159/000437052. Epub 2015 Aug 14.

5.

Kallmann syndrome with FGFR1 and KAL1 mutations detected during fetal life.

Sarfati J, Bouvattier C, Bry-Gauillard H, Cartes A, Bouligand J, Young J.

Orphanet J Rare Dis. 2015 Jun 9;10:71. doi: 10.1186/s13023-015-0287-9.

6.

Sex steroids, precursors, and metabolite deficiencies in men with isolated hypogonadotropic hypogonadism and panhypopituitarism: a GCMS-based comparative study.

Giton F, Trabado S, Maione L, Sarfati J, Le Bouc Y, Brailly-Tabard S, Fiet J, Young J.

J Clin Endocrinol Metab. 2015 Feb;100(2):E292-6. doi: 10.1210/jc.2014-2658. Epub 2014 Nov 13.

PMID:
25393641
7.

Pituitary stalk interruption and olfactory bulbs aplasia/hypoplasia in a man with Kallmann syndrome and reversible gonadotrope and somatotrope deficiencies.

Sarfati J, Saveanu A, Young J.

Endocrine. 2015 Aug;49(3):865-6. doi: 10.1007/s12020-014-0475-8. Epub 2014 Nov 9. No abstract available.

PMID:
25381604
8.

From adverse drug event detection to prevention. A novel clinical decision support framework for medication safety.

Koutkias VG, McNair P, Kilintzis V, Skovhus Andersen K, Niès J, Sarfati JC, Ammenwerth E, Chazard E, Jensen S, Beuscart R, Maglaveras N.

Methods Inf Med. 2014;53(6):482-92. doi: 10.3414/ME14-01-0027. Epub 2014 Nov 7.

PMID:
25377477
9.

The prevalence of CHD7 missense versus truncating mutations is higher in patients with Kallmann syndrome than in typical CHARGE patients.

Marcos S, Sarfati J, Leroy C, Fouveaut C, Parent P, Metz C, Wolczynski S, Gérard M, Bieth E, Kurtz F, Verier-Mine O, Perrin L, Archambeaud F, Cabrol S, Rodien P, Hove H, Prescott T, Lacombe D, Christin-Maitre S, Touraine P, Hieronimus S, Dewailly D, Young J, Pugeat M, Hardelin JP, Dodé C.

J Clin Endocrinol Metab. 2014 Oct;99(10):E2138-43. doi: 10.1210/jc.2014-2110. Epub 2014 Jul 31. Erratum in: J Clin Endocrinol Metab. 2015 Jan;100(1):317.

PMID:
25077900
10.

Congenital hypogonadotropic hypogonadism and Kallmann syndrome as models for studying hormonal regulation of human testicular endocrine functions.

Trabado S, Lamothe S, Maione L, Bouvattier C, Sarfati J, Brailly-Tabard S, Young J.

Ann Endocrinol (Paris). 2014 May;75(2):79-87. doi: 10.1016/j.ando.2014.04.011. Epub 2014 May 9. Review.

PMID:
24815726
11.

Insulin-like peptide 3 (INSL3) in men with congenital hypogonadotropic hypogonadism/Kallmann syndrome and effects of different modalities of hormonal treatment: a single-center study of 281 patients.

Trabado S, Maione L, Bry-Gauillard H, Affres H, Salenave S, Sarfati J, Bouvattier C, Delemer B, Chanson P, Le Bouc Y, Brailly-Tabard S, Young J.

J Clin Endocrinol Metab. 2014 Feb;99(2):E268-75. doi: 10.1210/jc.2013-2288. Epub 2013 Nov 15.

PMID:
24243640
12.

Greater prevalence of PROKR2 mutations in Kallmann syndrome patients from the Maghreb than in European patients.

Sarfati J, Fouveaut C, Leroy C, Jeanpierre M, Hardelin JP, Dodé C.

Eur J Endocrinol. 2013 Oct 21;169(6):805-9. doi: 10.1530/EJE-13-0419. Print 2013 Dec.

PMID:
24031091
13.

SEMA3A deletion in a family with Kallmann syndrome validates the role of semaphorin 3A in human puberty and olfactory system development.

Young J, Metay C, Bouligand J, Tou B, Francou B, Maione L, Tosca L, Sarfati J, Brioude F, Esteva B, Briand-Suleau A, Brisset S, Goossens M, Tachdjian G, Guiochon-Mantel A.

Hum Reprod. 2012 May;27(5):1460-5. doi: 10.1093/humrep/des022. Epub 2012 Mar 12.

PMID:
22416012
14.

Impact of clinical, hormonal, radiological, and immunohistochemical studies on the diagnosis of postmenopausal hyperandrogenism.

Sarfati J, Bachelot A, Coussieu C, Meduri G, Touraine P; Study Group Hyperandrogenism in Postmenopausal Women.

Eur J Endocrinol. 2011 Nov;165(5):779-88. doi: 10.1530/EJE-11-0542. Epub 2011 Sep 6.

PMID:
21896622
15.

REMOVAL: Pelvic MRI in a 17-year-old XY girl with 5-alpha reductase deficiency and a homozygous Gly115Asp mutation in SRD5A2.

Sarfati J, Trabado S, Rocher L, Mallet D, Betari-Tabet B, Morel Y, Young J.

Ann Endocrinol (Paris). 2011 Sep;72(4):310-313. doi: 10.1016/j.ando.2011.07.001. Epub 2011 Aug 10.

PMID:
21835392
16.

Three different cases of exploiting decision support services for adverse drug event prevention.

Bernonille S, Nies J, Pedersen HG, Guillot B, Maazi M, Berg AL, Sarfati JC, Koutkias V.

Stud Health Technol Inform. 2011;166:180-8.

PMID:
21685623
17.

[Obesity and female reproduction].

Sarfati J, Young J, Christin-Maitre S.

Ann Endocrinol (Paris). 2010 Sep;71 Suppl 1:S49-53. doi: 10.1016/S0003-4266(10)70007-X. French.

PMID:
21237331
18.

[The adult ovary is not in sleepiness: major role of forkhead proteins].

Sarfati J, Young J, Christin-Maitre S.

Ann Endocrinol (Paris). 2010 Sep;71 Suppl 1:S42-8. doi: 10.1016/S0003-4266(10)70006-8. Review. French.

PMID:
21237330
19.

[Evaluation of a dysphonic population. Interest of a therapeutic team composed by the phoniatrician and the speech therapist].

Sarfati J, Cabaret P, Charmettant C, Muet-Choquart C, Dauphin C, Noguine B, Josien S, Leymarie-Selles A, Maître N, Perret E, Vintenat-Touchard MA, Vitale-Terle C, Selles M, Morel N.

Rev Laryngol Otol Rhinol (Bord). 2010;131(1):65-7. French.

PMID:
21086661
20.

[Callas or the trajectory of the meteor].

Epron JP, Sarfati J, Henrich N.

Rev Laryngol Otol Rhinol (Bord). 2010;131(1):35-8. French.

PMID:
21086657
21.

Members of protein O-mannosyltransferase family in Aspergillus fumigatus differentially affect growth, morphogenesis and viability.

Mouyna I, Kniemeyer O, Jank T, Loussert C, Mellado E, Aimanianda V, Beauvais A, Wartenberg D, Sarfati J, Bayry J, Prévost MC, Brakhage AA, Strahl S, Huerre M, Latgé JP.

Mol Microbiol. 2010 Jun 1;76(5):1205-21. doi: 10.1111/j.1365-2958.2010.07164.x. Epub 2010 Apr 14.

22.

Kallmann syndrome caused by mutations in the PROK2 and PROKR2 genes: pathophysiology and genotype-phenotype correlations.

Sarfati J, Dodé C, Young J.

Front Horm Res. 2010;39:121-132. doi: 10.1159/000312698. Epub 2010 Apr 8. Review.

PMID:
20389090
23.

Congenital hypogonadotropic hypogonadism in females: clinical spectrum, evaluation and genetics.

Bry-Gauillard H, Trabado S, Bouligand J, Sarfati J, Francou B, Salenave S, Chanson P, Brailly-Tabard S, Guiochon-Mantel A, Young J.

Ann Endocrinol (Paris). 2010 May;71(3):158-62. doi: 10.1016/j.ando.2010.02.024. Epub 2010 Apr 3. Review.

PMID:
20363464
24.

A comparative phenotypic study of kallmann syndrome patients carrying monoallelic and biallelic mutations in the prokineticin 2 or prokineticin receptor 2 genes.

Sarfati J, Guiochon-Mantel A, Rondard P, Arnulf I, Garcia-Piñero A, Wolczynski S, Brailly-Tabard S, Bidet M, Ramos-Arroyo M, Mathieu M, Lienhardt-Roussie A, Morgan G, Turki Z, Bremont C, Lespinasse J, Du Boullay H, Chabbert-Buffet N, Jacquemont S, Reach G, De Talence N, Tonella P, Conrad B, Despert F, Delobel B, Brue T, Bouvattier C, Cabrol S, Pugeat M, Murat A, Bouchard P, Hardelin JP, Dodé C, Young J.

J Clin Endocrinol Metab. 2010 Feb;95(2):659-69. doi: 10.1210/jc.2009-0843. Epub 2009 Dec 18.

PMID:
20022991
25.

Detection of adverse drug events: proposal of a data model.

Chazard E, Merlin B, Ficheur G, Sarfati JC; PSIP Consortium, Beuscart R.

Stud Health Technol Inform. 2009;148:63-74.

PMID:
19745236
26.

Immune sensing of Aspergillus fumigatus proteins, glycolipids, and polysaccharides and the impact on Th immunity and vaccination.

Bozza S, Clavaud C, Giovannini G, Fontaine T, Beauvais A, Sarfati J, D'Angelo C, Perruccio K, Bonifazi P, Zagarella S, Moretti S, Bistoni F, Latgé JP, Romani L.

J Immunol. 2009 Aug 15;183(4):2407-14. doi: 10.4049/jimmunol.0900961. Epub 2009 Jul 22.

27.

Impact of combined and progestogen-only contraceptives on bone mineral density.

Sarfati J, de Vernejoul MC.

Joint Bone Spine. 2009 Mar;76(2):134-8. doi: 10.1016/j.jbspin.2008.09.014. Epub 2009 Feb 1. Review.

PMID:
19181558
28.

Effects of conidia of various Aspergillus species on apoptosis of human pneumocytes and bronchial epithelial cells.

Féménia F, Huet D, Lair-Fulleringer S, Wagner MC, Sarfati J, Shingarova L, Guillot J, Boireau P, Chermette R, Berkova N.

Mycopathologia. 2009 May;167(5):249-62. doi: 10.1007/s11046-008-9175-3. Epub 2009 Jan 1.

PMID:
19117118
29.

Generation and characterization of anti-Candida T cells as potential immunotherapy in patients with Candida infection after allogeneic hematopoietic stem-cell transplant.

Tramsen L, Beck O, Schuster FR, Hunfeld KP, Latgé JP, Sarfati J, Röger F, Klingebiel T, Koehl U, Lehrnbecher T.

J Infect Dis. 2007 Aug 1;196(3):485-92. Epub 2007 Jun 18.

PMID:
17597464
30.

The GPI-anchored Gas and Crh families are fungal antigens.

Arroyo J, Sarfati J, Baixench MT, Ragni E, Guillén M, Rodriguez-Peña JM, Popolo L, Latgé JP.

Yeast. 2007 Apr;24(4):289-96.

31.

[Communication disorders marked with hypophonia. Indication and speech therapy through the LSVT method].

Cabaret P, Sarfati J.

Rev Laryngol Otol Rhinol (Bord). 2007;128(5):325-8. French.

PMID:
20387379
32.

The role of the sakA (Hog1) and tcsB (sln1) genes in the oxidant adaptation of Aspergillus fumigatus.

Du C, Sarfati J, Latge JP, Calderone R.

Med Mycol. 2006 May;44(3):211-8.

PMID:
16702099
33.
34.

Glycosylphosphatidylinositol-anchored Ecm33p influences conidial cell wall biosynthesis in Aspergillus fumigatus.

Chabane S, Sarfati J, Ibrahim-Granet O, Du C, Schmidt C, Mouyna I, Prevost MC, Calderone R, Latgé JP.

Appl Environ Microbiol. 2006 May;72(5):3259-67.

35.

Recombinant antigens as diagnostic markers for aspergillosis.

Sarfati J, Monod M, Recco P, Sulahian A, Pinel C, Candolfi E, Fontaine T, Debeaupuis JP, Tabouret M, Latgé JP.

Diagn Microbiol Infect Dis. 2006 Aug;55(4):279-91. Epub 2006 Apr 19.

PMID:
16626916
36.

Generation of highly purified and functionally active human TH1 cells against Aspergillus fumigatus.

Beck O, Topp MS, Koehl U, Roilides E, Simitsopoulou M, Hanisch M, Sarfati J, Latgé JP, Klingebiel T, Einsele H, Lehrnbecher T.

Blood. 2006 Mar 15;107(6):2562-9. Epub 2005 Dec 1.

37.

Deletion of GEL2 encoding for a beta(1-3)glucanosyltransferase affects morphogenesis and virulence in Aspergillus fumigatus.

Mouyna I, Morelle W, Vai M, Monod M, Léchenne B, Fontaine T, Beauvais A, Sarfati J, Prévost MC, Henry C, Latgé JP.

Mol Microbiol. 2005 Jun;56(6):1675-88.

38.

[Evaluation of vocal abuse by the patient and correlation with vocal cords lesions].

Sarfati J, Epron JP.

Rev Laryngol Otol Rhinol (Bord). 2003;124(5):345-8. French.

PMID:
15144034
39.

Cell wall biogenesis in a double chitin synthase mutant (chsG-/chsE-) of Aspergillus fumigatus.

Mellado E, Dubreucq G, Mol P, Sarfati J, Paris S, Diaquin M, Holden DW, Rodriguez-Tudela JL, Latgé JP.

Fungal Genet Biol. 2003 Feb;38(1):98-109.

PMID:
12553940
40.

Molecular characterization of a cell wall-associated beta(1-3)endoglucanase of Aspergillus fumigatus.

Mouyna I, Sarfati J, Recco P, Fontaine T, Henrissatz B, Latge JP.

Med Mycol. 2002 Oct;40(5):455-64.

PMID:
12462524
41.

A new experimental murine aspergillosis model to identify strains of Aspergillus fumigatus with reduced virulence.

Sarfati J, Diaquin M, Debeaupuis JP, Schmidt A, Lecaque D, Beauvais A, Latge JP.

Nihon Ishinkin Gakkai Zasshi. 2002;43(4):203-13. Review.

42.

Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies.

Hebart H, Bollinger C, Fisch P, Sarfati J, Meisner C, Baur M, Loeffler J, Monod M, Latgé JP, Einsele H.

Blood. 2002 Dec 15;100(13):4521-8. Epub 2002 Aug 1.

43.

Rule 6 of the Health Information Privacy Code 1994.

Sarfati J.

N Z Med J. 2001 Sep 28;114(1140):436. No abstract available.

PMID:
11700761
44.
45.

[Value of the relative phonetogram (RP) for the evaluation of organic dysphonias].

Hilgenheger C, Sarfati J, Reyt E, Sittel C, Eckel HE.

Rev Laryngol Otol Rhinol (Bord). 1999;120(4):231-7. French.

PMID:
10668357
46.

Comparative study of serological tests for the diagnosis of equine aspergillosis.

Guillot J, Sarfati J, de Barros M, Cadoré JL, Jensen HE, Chermette R.

Vet Rec. 1999 Sep 18;145(12):348-9. Review. No abstract available.

PMID:
10530885
47.

Molecular diagnosis and epidemiology of fungal infections.

Reiss E, Tanaka K, Bruker G, Chazalet V, Coleman D, Debeaupuis JP, Hanazawa R, Latgé JP, Lortholary J, Makimura K, Morrison CJ, Murayama SY, Naoe S, Paris S, Sarfati J, Shibuya K, Sullivan D, Uchida K, Yamaguchi H.

Med Mycol. 1998;36 Suppl 1:249-57. Review.

PMID:
9988514
48.

Detection of Aspergillus galactomannan: comparison of an enzyme-linked immunoassay and a europium-linked time-resolved fluoroimmunoassay.

Paugam A, Sarfati J, Romieu R, Viguier M, Dupouy-Camet J, Latgé JP.

J Clin Microbiol. 1998 Oct;36(10):3079-80.

49.

Molecular typing of environmental and patient isolates of Aspergillus fumigatus from various hospital settings.

Chazalet V, Debeaupuis JP, Sarfati J, Lortholary J, Ribaud P, Shah P, Cornet M, Vu Thien H, Gluckman E, Brücker G, Latgé JP.

J Clin Microbiol. 1998 Jun;36(6):1494-500.

50.

Comparison of an enzyme immunoassay and a latex agglutination system for the diagnosis of invasive aspergillosis in bone marrow transplant recipients.

Machetti M, Feasi M, Mordini N, Van Lint MT, Bacigalupo A, Latgé JP, Sarfati J, Viscoli C.

Bone Marrow Transplant. 1998 May;21(9):917-21.

Supplemental Content

Loading ...
Support Center